BD - Earth day 2024

Bracco Imaging launches the EmpowerCTA®+ The Next Generation of Contrast Enhanced Delivery Systems in CT Imaging

Saturday, March 07, 2015

Bracco Imaging, through its business unit Bracco Injeneering SA, announced today the availability of its EmpowerCTA+, an advanced engineering contrast injection system that puts the radiologic technologist in control, in the computed tomography suite.

The EmpowerCTA+ has initially been launched in the United States then gradually in Europe, and it will be presented at the upcoming European Congress of Radiology (ECR, Vienna, 4-8 March 2015).

The EmpowerCTA+ contrast injection system has been reengineered, setting a new standard in the contrast power injectors market. The system was designed to streamline workflow, with enhanced safety and control at the patient side.

Bracco’s EmpowerCTA+ was reengineered with an intuitive and intelligent design with technological enhancements, in tune with the needs of patients, radiologic technologists and the healthcare marketplace. Its advanced touchscreen technology enables technologists to customize the contrast injection experience right at the patient’s side with new enhancements, including real time variable flow rates, saline advance, and saline jump.

“We are extremely pleased to announce the availability on the market of the EmpowerCTA+,“ said Vittorio Puppo, Head of Business Unit Injectors and President & CEO at Bracco Diagnostics Inc. “The contrast injector system was reengineered with digital touch technology and a new visionary design with high performance, which will help us to increase market penetration.”

EmpowerCTA+ has a saline advance function which tests a patient’s patency and vein integrity while its saline jump feature minimizes the amount of contrast a patient receives. The injector’s unique patented EDA™ (extravasation detection accessory) advances patient care while providing additional safety and peace of mind for the technologist. In addition, its eGFR calculator simplifies calculations for kidney evaluation function prior to contrast delivery. The risk of air embolisms to the patient is reduced due to the system’s built-in tilt sensor and lock. Technologists have greater control with the touchscreen technology at the patient’s side.

 

Source : http://finance.yahoo.com/